Skip to main content
OpenTrials
Completed

NCT Number: NCT04448548

Possible Roles of MDW in Infection Management in Emergency Care

A retrospective study to determine the potential value of MDW among other biomarkers in the diagnosis of infection.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Szeged, Emergency Department

Szeged, Hungary

About this study

MDW as a novel indicator can be useful in clinical practice in the emergency care. However, until now, no study has been published about MDW's general relationship and coherence with multiple, conventional laboratory tests for infections, such as PCT, C-reactive protein (CRP), WBC, neutrophil count (NC), neutrophil percentage and immature granulocyte count (IGC) together.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult (18+ years), receiving care for suspected infection

Exclusion criteria

  • refuses to sign the consent form

Treatment and study plan

blood sample taking

Other

For study purposes, blood sample was taken during the first medical examination from patients with suspected infection.

Primary outcomes

  1. MDW cutoff value for infection

    Time frame: 4 months

    Cutoff value for MDW indicating infection

Sponsors and collaborators

Lead sponsor

Szeged University

Other

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jun 26, 2020
Registry last updated
Jun 26, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.